StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
PepGen Inc.
NasdaqGS:PEPG
Sector
Industries
Location
Market Cap
USD 47.45 M
Share Price
USD 1.45
Avg Daily Volume
243,301
Change (1 day)
0.69%
Change (1 year)
-91.95%
Change (YTD)
-61.74%
PepGen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -82.77 M
PepGen Inc. Operating Cash Flow is USD -82.77 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 8.75% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
PepGen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -76.11 M, a 21.94% change year over year.
-
PepGen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -62.41 M, a 94.80% change year over year.
-
PepGen Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -32.04 M.
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%